Johnson & Johnson (JNJ): Price and Financial Metrics

Johnson & Johnson (JNJ): $178.90

0.12 (+0.07%)

POWR Rating

Component Grades














  • JNJ scores best on the Stability dimension, with a Stability rank ahead of 96.19% of US stocks.
  • JNJ's strongest trending metric is Quality; it's been moving up over the last 177 days.
  • JNJ ranks lowest in Momentum; there it ranks in the 12th percentile.

JNJ Stock Summary

  • JNJ has a market capitalization of $467,417,379,259 -- more than approximately 99.85% of US stocks.
  • JOHNSON & JOHNSON's stock had its IPO on January 1, 1986, making it an older stock than 93.49% of US equities in our set.
  • The volatility of JOHNSON & JOHNSON's share price is greater than that of only 0.63% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to JOHNSON & JOHNSON, a group of peers worth examining would be XOM, TSM, UNH, LLY, and V.
  • JNJ's SEC filings can be seen here. And to visit JOHNSON & JOHNSON's official web site, go to

JNJ Valuation Summary

  • JNJ's EV/EBIT ratio is 21.7; this is 155.29% higher than that of the median Healthcare stock.
  • Over the past 243 months, JNJ's EV/EBIT ratio has gone up 1.

Below are key valuation metrics over time for JNJ.

Stock Date P/S P/B P/E EV/EBIT
JNJ 2022-12-01 4.9 6.3 24.4 21.7
JNJ 2022-11-30 4.8 6.2 24.3 21.6
JNJ 2022-11-29 4.8 6.2 24.0 21.4
JNJ 2022-11-28 4.8 6.2 24.2 21.5
JNJ 2022-11-25 4.8 6.2 24.2 21.5
JNJ 2022-11-23 4.8 6.2 24.2 21.5

JNJ Growth Metrics

    Its 3 year cash and equivalents growth rate is now at -28.99%.
  • Its 5 year cash and equivalents growth rate is now at -18.14%.
  • Its 3 year price growth rate is now at 27.13%.
JNJ's revenue has moved up $15,357,000,000 over the prior 52 months.

The table below shows JNJ's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 96,041 21,576 19,157
2022-06-30 95,588 23,582 18,366
2022-03-31 94,880 23,315 19,830
2021-12-31 93,775 23,410 20,878
2021-09-30 91,446 26,021 17,880
2021-06-30 89,190 26,114 17,767

JNJ's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • JNJ has a Quality Grade of B, ranking ahead of 92.45% of graded US stocks.
  • JNJ's asset turnover comes in at 0.52 -- ranking 78th of 682 Pharmaceutical Products stocks.
  • CBIO, CLSD, and ABBV are the stocks whose asset turnover ratios are most correlated with JNJ.

The table below shows JNJ's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-03 0.520 0.675 0.295
2021-07-04 0.514 0.670 0.302
2021-04-04 0.498 0.662 0.273
2021-01-03 0.501 0.656 0.272
2020-09-27 0.504 0.657 0.332
2020-06-28 0.514 0.657 0.307

JNJ Price Target

For more insight on analysts targets of JNJ, see our JNJ price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $187.95 Average Broker Recommendation 1.53 (Moderate Buy)

JNJ Stock Price Chart Interactive Chart >

Price chart for JNJ

JNJ Price/Volume Stats

Current price $178.90 52-week high $186.69
Prev. close $178.78 52-week low $155.72
Day low $178.90 Volume 3,250
Day high $178.90 Avg. volume 7,311,908
50-day MA $170.56 Dividend yield 2.53%
200-day MA $172.69 Market Cap 467.73B

Johnson & Johnson (JNJ) Company Bio

Founded in 1886, Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture, and sale of products in the healthcare field within its Consumer, Pharmaceutical and Medical Devices segments. The Consumer segment consists of skin and self-care product brand names such as Aveeno, Neutrogena, Rogaine, Tylenol, Motrin, Listerine, and Band-Aid. Johnson’s Pharmaceutical segment contains biopharma products that address immune, cardiovascular, metabolic, and infectious disease medical conditions. The Medical Device segment develops products centered around orthopedic, surgical, intervention, and vision solutions. The company has over 130,000 employees worldwide and is headquartered in New Brunswick, New Jersey. The company’s current Chief Executive Officer is Alex Gorsky.

JNJ Latest News Stream

Event/Time News Detail
Loading, please wait...

JNJ Latest Social Stream

Loading social stream, please wait...

View Full JNJ Social Stream

Latest JNJ News From Around the Web

Below are the latest news stories about JOHNSON & JOHNSON that investors may wish to consider to help them evaluate JNJ as an investment opportunity.

11 Best Quality Stocks to Buy Now

In this article, we will take a look at the 11 best quality stocks to buy now. If you want to see more stocks in this selection, go to the 5 Best Quality Stocks to Buy Now. During these uncertain times, when the Federal Reserve is on a mission to fight inflation by increasing benchmark […]

Yahoo | December 5, 2022

Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi

Johnson & Johnson dropped out of the bidding process for Horizon Therapeutics, pushing HZNP stock into the red on Monday.

Yahoo | December 5, 2022

10 Best Jim Cramer Stocks to Buy Now

In this article, we will take a look at 10 best Jim Cramer stocks to buy now. If you want to see more best Jim Cramer stocks to buy, go directly to 5 Best Jim Cramer Stocks to Buy Now. Jim Cramer is a famous TV personality who hosts the show Mad Money. He is […]

Yahoo | December 5, 2022

If You Bought 100 Shares of Johnson & Johnson 10 Years Ago, This Is How Much You Would Have Today

The stability of Johnson & Johnson (NYSE: JNJ) has attracted investors for a long time. The healthcare company with more than 140,000 employees is a Dividend King that has raised its quarterly dividend annually for 60 consecutive years, including a 6.6% bump this year to $1.13 per share, resulting in a yield of about 2.58%. The company has built-in diversity because it is so large and operates in three segments: pharmaceuticals, medtech, and consumer healthcare.

Yahoo | December 5, 2022

13 Best Bear Market Stocks To Buy Now

In this article, we discuss the 13 best bear market stocks to buy now. If you want to see more stocks in this selection, go directly to the 5 Best Bear Market Stocks To Buy Now. Since the start of 2022, the S&P 500 Index has observed a decline of 15.5%. The index also remained […]

Yahoo | December 4, 2022

Read More 'JNJ' Stories Here

JNJ Price Returns

1-mo 5.00%
3-mo 9.74%
6-mo 4.35%
1-year 12.68%
3-year 37.73%
5-year 45.84%
YTD 7.32%
2021 11.44%
2020 10.82%
2019 16.22%
2018 -5.13%
2017 24.43%

JNJ Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full JNJ Dividend History

Continue Researching JNJ

Want to see what other sources are saying about Johnson & Johnson's financials and stock price? Try the links below:

Johnson & Johnson (JNJ) Stock Price | Nasdaq
Johnson & Johnson (JNJ) Stock Quote, History and News - Yahoo Finance
Johnson & Johnson (JNJ) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7758 seconds.